Prosecution Insights
Last updated: November 05, 2026
Application No. 18/561,642

Agricultural Chemical Formulation

Final Rejection §102§112
Filed
Nov 16, 2023
Priority
May 28, 2021 — provisional 63/194,422 +2 more
Examiner
NGUYEN, NGOC-ANH THI
Art Unit
1615
Tech Center
1600 — Biotechnology & Organic Chemistry
Assignee
Aaron Eberle
OA Round
2 (Final)
30%
Grant Probability
At Risk
3-4
OA Rounds
6m
Est. Remaining
76%
With Interview

Examiner Intelligence

Grants only 30% of cases
30%
Career Allowance Rate
20 granted / 67 resolved
-30.1% vs TC avg
Strong +46% interview lift
Without
With
+46.5%
Interview Lift
resolved cases with interview
Typical timeline
3y 5m
Avg Prosecution
45 currently pending
Career history
123
Total Applications
across all art units

Statute-Specific Performance

§101
2.4%
-37.6% vs TC avg
§103
55.0%
+15.0% vs TC avg
§102
20.9%
-19.1% vs TC avg
§112
15.8%
-24.2% vs TC avg
Black line = Tech Center average estimate • Based on career data from 67 resolved cases

Office Action

§102 §112
DETAILED ACTION Notice of Pre-AIA or AIA Status The present application, filed on or after March 16, 2013, is being examined under the first inventor to file provisions of the AIA . Status of Application Applicants' arguments/remarks filed 05/12/2026 are acknowledged. Claim 15-20 are newly added. Claims 1-12, 14 and 15-20 are examined on the merits within and are currently pending. Specification Objections The disclosure is objected to because of the following informalities: C9-C15alkyl, C1-C4alkyl; C4-C8alkyl, C9alkyl, which should have a space before alkyl. For example, C9-C15 alkyl. Appropriate correction is required. Claim Objections Claims 1-4 and 15 are objected to because of the following informalities: C9-C15alkyl, C1-C4alkyl; C4-C8alkyl, C9alkyl, which should have a space before alkyl. For example, C9-C15 alkyl Appropriate correction is required. Modified Claim Rejections Claim Rejections - 35 USC § 112 The following is a quotation of 35 U.S.C. 112(d): (d) REFERENCE IN DEPENDENT FORMS. Subject to subsection (e), a claim in dependent form shall contain a reference to a claim previously set forth and then specify a further limitation of the subject matter claimed. A claim in dependent form shall be construed to incorporate by reference all the limitations of the claim to which it refers. The following is a quotation of pre-AIA 35 U.S.C. 112, fourth paragraph: Subject to the following paragraph [i.e., the fifth paragraph of pre-AIA 35 U.S.C. 112], a claim in dependent form shall contain a reference to a claim previously set forth and then specify a further limitation of the subject matter claimed. A claim in dependent form shall be construed to incorporate by reference all the limitations of the claim to which it refers. Claims 15-17 are rejected under 35 U.S.C. 112(d) or pre-AIA 35 U.S.C. 112, 4th paragraph, as being of improper dependent form for failing to further limit the subject matter of the claim upon which it depends, or for failing to include all the limitations of the claim upon which it depends. Applicant may cancel the claim(s), amend the claim(s) to place the claim(s) in proper dependent form, rewrite the claim(s) in independent form, or present a sufficient showing that the dependent claim(s) complies with the statutory requirements. Claim 15 is rejected under 35 U.S.C. 112(d) because it is duplicated exactly from claim 3. Claim 16 is rejected under 35 U.S.C. 112(d) because it is substantially duplicated exactly from claim 4. Claim 17 is rejected under 35 U.S.C. 112(d) because it is substantially duplicated exactly from claim 5. Claim Rejections - 35 USC § 102 The following is a quotation of the appropriate paragraphs of 35 U.S.C. 102 that form the basis for the rejections under this section made in this Office action: A person shall be entitled to a patent unless – (a)(1) the claimed invention was patented, described in a printed publication, or in public use, on sale, or otherwise available to the public before the effective filing date of the claimed invention. (a)(2) the claimed invention was described in a patent issued under section 151, or in an application for patent published or deemed published under section 122(b), in which the patent or application, as the case may be, names another inventor and was effectively filed before the effective filing date of the claimed invention. Claims 1, 2, 6-12 and 14 are rejected under 35 U.S.C. 102(a)(1) as being anticipated by Mertoglu et al. (US 20160021877Al). Claims 1 and 2, Mertoglu et al. teach an emulsifiable concentrate comprising a water-insoluble pesticide, an alkyl benzoate, and an amide of the formula (I). (Abs). The object was achieved by an emulsifiable concentrate comprising a water-insoluble pesticide, an alkyl benzoate, and an amide of the formula (I) R1-C(O)N(R2)2 (I), where R1 is C5 -C19-alkyl and R2 is C1-C4 -alkyl. (0004). Suitable alkyl benzoates are alkyl benzoates where the phenyl group is optionally substituted with at least one alkyl group. Preferably, the alkyl benzoate is a linear or branched C1-12 alkyl benzoate, more preferably a linear or branched C1-6 alkyl benzoate, and in particular a linear or branched Cm alkyl benzoate. (0007). The emulsifiable concentrate can furthermore comprise auxiliaries conventionally used for crop protection products. Suitable auxiliaries are solvents, liquid carriers, surfactants, dispersants, emulsifiers, wetters, adjuvants, solubilizers, penetrants, protective colloids, stickers, thickeners, bactericides, antifreeze agents, antifoam agents, colorants, adhesives and binders. (0088). An alkyl is not specified straight, branch, or cyclic then an alkyl group can be a straight, branch or cyclic alkyl, unless otherwise specified. With regard to claim 6, Butyl benzoate. (0111). With regard to claim 7, The concentrate may comprise from 0.1 to 60% by weight, of pesticide, the basis being the total of all the pesticides present in the concentrate. (0087). The concentrate can comprise not more than 80% by weight of the alkyl benzoate. (0010). The concentrate preferably comprises at least one anionic surfactant. The concentrate usually comprises not less than 0.5% by weight of anionic surfactants. The composition can comprise not more than 30% by weight of anionic surfactants. (0096). With regard to claim 8, Mertoglu et al. teach Pesticides refer to at least one active substance selected from the group of the fungicides, insecticides, nematicides, herbicides, safeners and/or growth regulators. (0021). With regard to claim 9, Mertoglu et al. teach dinitroanilines: benfluralin, ethalfluralin, oryzalin, pendimethalin, prodiamine, trifluralin; (0055). With regard to claim 10, Mertoglu et al. teach an emulsifiable concentrate comprising a water-insoluble pesticide, an alkyl benzoate, and an amide of the formula (I). (Abs). formula (I) R1-C(O)N(R2)2 (I), where R1 is C5 -C19-alkyl and R2 is C1-C4 -alkyl. (0004). Growth Regulators include naphthaleneacetic acid (NAA), (0048), picloram, Clopyralid (0061), which are synthetic auxins. With regard to claim 11, Mertoglu et al. teach Suitable surfactants are surface-active compounds, such as anionic, cationic, nonionic and amphoteric surfactants. (0090). The concentrate preferably comprises at least one anionic surfactant. The concentrate usually comprises not less than 0.5% by weight of anionic surfactants, preferably not less than 2% by weight not more than 30% by weight of anionic surfactants, preferably not more than 15% by weight and in particular not more than 10% by weight. (0096). The concentrate preferably comprises at least one nonionic surfactant (such as alkoxylates). The concentrate usually comprises not less than 1 % by weight of nonionic surfactants, preferably not less than 5% by weight and in particular not less than 10% by weight. The composition can comprise not more than 65% by weight of nonionic surfactants, preferably not more than 45% by weight and in particular not more than 35% by weight. (0097). In a preferred form, the concentrate preferably comprises at least one alkoxylate, in particular an alkoxylated CcC22-alcohol. The concentrate usually comprises not less than 2% by weight of alkoxylates (in particular an alkoxylated C6-C22-alcohol), preferably not less than 7% by weight and in particular not less than 10% by weight. (0098). Preferably, the concentrate comprises a nonionic surfactant (such as alkoxylates) and an anionic surfactant ( such as sulfates or sulfonates). [0099] With regard to claims 12 and 14, Mertoglu et al. teach The present invention is an emulsifiable concentrate comprising a water-insoluble pesticide, an alkyl benzoate, and an amide of the formula (I). The preparation of said concentrate; an emulsion obtainable by mixing water, a water-insoluble pesticide, the alkyl benzoate, and the amide; and to a method for controlling phytopathogenic fungi and/or undesired vegetation and/or undesired attack by insects or mites and/or for regulating the growth of plants, where the concentrate or the emulsion is allowed to act on the respective pests, their environment or on the crop plants to be protected from the respective pests, on the soil and/or on undesired plants and/or on the crop plants and/or their environment. (Abs). With regard to claim 20, Mertoglu et al. teach Composition E, R or G, has total percentages of all active ingredient, the one or more solvents, and the one of more surfactants together 12+2.5+15 (or 10) + 14 + 49 (or 54) = 92.5% (Table 4, 0133) Claim 1 is rejected under 35 U.S.C. 102(a)(1) as being anticipated by Yin et al. (US 8653121B2). Yin et al. teach: An agrochemical composition comprises an azole active ingredient and an N,N-dialkyl long chain alkylamide. Preferred N,N-Dialkyl long chain alkylamide(s) comprised in the composition is/are selected from the group consisting of compounds of the formula (I) below: in which (a) R1 and R2 are independently normal alkyl radicals having 2 carbon atoms, and R represents an alkyl group having from 10 to 30 carbon atoms; or (b) R1 and R2 are independently normal alkyl radicals having 3 carbon atoms, and R represents an alkyl group having from 9 to 30 carbon atoms; or 20 (c) R1 and R2 are independently normal alkyl radicals having from 4 to 20 carbon atoms and R represents an alkyl group having from 6 to 30 carbon atoms. (Abs) PNG media_image1.png 78 115 media_image1.png Greyscale And an emulsifier (surfactant). (Tables 1-11 and 13-15 and Claim 14, Col. 30). An alkyl is not specified straight, branch, or cyclic then an alkyl group can be a straight, branch or cyclic alkyl, unless otherwise specified. Claims 1-2 are rejected under 35 U.S.C. 102(a)(1) as being anticipated by Horstmann et al. (US 5206225 A). Horstmann et al. teach: the new use of certain alkyl carboxylic acid dimethyl amides for prevention of crystallization during the application of aqueous spray liquors based on specific pesticidally active compounds. (Col. 1, lines 5-9). An alkyl carboxylic acid dimethyl amide of the formula (I) below, in which R represent alkyl having 5-19 carbon atoms (Abs). The composition comprises emulsifier (Col. 10, line 46, Col. 11, lines 16, 67, Col 12, lines 48, 60, Col. 13, lines 1, 31, 66). surface-active substances in this case are non-ionic and anionic emulsifiers. The emulsifiers can be employed individually or, alternatively, in a mixture. (Col. 7, lines 28-68-Col. 8, lines 1-50). An alkyl is not specified straight, branch, or cyclic then a straight, branch or cyclic alkyl belong to alkyl group. PNG media_image2.png 64 127 media_image2.png Greyscale Claims 1 and 2 are rejected under 35 U.S.C. 102(a)(1) as being anticipated by Bennett et al. (US 11160281 B2). Bennett et al. teach a safener containing herbicidal oil dispersion. An oil dispersion is described containing a base oil, an herbicide composition including a comprising flucarbazone sodium and/or fenoxaprop-p-ethyl, an herbicidal safener comprising cloquintocet-mexyl, and a carrier comprising an alkyl benzoate. The dispersion demonstrates enhanced dilution, and high and low temperature stability. (Abs). An alkyl benzoate having an alkyl containing up to 10 carbon atoms. (Col. 2, lines 12-13). Butyl benzoate, other benzoates can be used as well, for example C1 , C2 , C3 , C5 , C6 , etc. as well as the C4 ( butyl ) form. (Col. 5, lines 56-58). PNG media_image3.png 183 250 media_image3.png Greyscale Claims 1 and 19 are rejected under 35 U.S.C. 102(a)(1) as being anticipated by Zen (US 20040063583A1). Zen teaches a low-irritant pesticidal emulsifiable concentrate comprising (a) 1 to 60% by weight of at least one pesticidal active ingredient compound; (b) 2 to 15% by weight of at least one surfactant and (c) 15 to 90% by weight of at least one aromatic ester Solvent represented by the formula: Ar-X-COOR (1), which teaches applicant claim 1c limitations or the formula: RCOO-X-Ar (2), which teaches applicant claim 1b limitations wherein R represents non-aromatic group having 1 to 6 carbon atoms, Ar represents an aromatic group; and X represents a single bond or an alkylene group having 1 to 6 carbon atoms. The pesticidal emulsifiable concentrate of the present invention can be used as an emulsion which is superior in emulsion stability when using after diluting with water, and has low irritation. (Abs). In the aromatic ester solvent used in the present invention, Ar of formula 1 and formula 2) is preferably a phenyl group which may be substituted with at least one methyl group, etc., X is preferably a single bond, a methylene group or an ethylene group; R is preferably an alkyl group having 1 to 6 carbon atoms. (0015). PNG media_image4.png 91 95 media_image4.png Greyscale An alkyl is not specified straight, branch, or cyclic then a straight, branch or cyclic alkyl belong to alkyl group. Response to Arguments Rejection under 35 U.S.C. § 102, Rejection 1: Applicant argues that Mertoglu fails to disclose "(a) an amide of formula R1-C(O)-NR2R3, wherein R1 is a branched C9-C1salkyl and R2 and R3 are independently C1-C4alkyl," as set forth in independent claim 1. In contrast, Mertoglu describes that formula (I) of Mertoglu is "R1-C(O)N(R2)2 where R1 is Cs-C19-alkyl and R2 is C1-C4-alkyl". However, Mertoglu is silent with respect to R1 of formula (I) being branched. Indeed, to the extent Mertoglu mentions any functional group being branched, Mertoglu describes an alkyl benzoate that is "a linear or branched C1-12 alkyl benzoate." See Mertoglu, para. 7. However, Mertoglu does not mention an amide including a branched hydrocarbon. Accordingly, Mertoglu does not disclose the amide (a) set forth in independent claim 1. Applicant's arguments have been fully considered but they are not persuasive, since Mertoglu teaches R1 is C5 -C19-alkyl, without specifying branched or not, which means it inherently embraces both straight-chain (unbranched) and branched-chain saturated hydrocarbon radicals. Applicant argues that Mertoglu appears to disclose a general alkyl benzoate where the carbonyl group is attached to the benzyl group. The alkyl benzoate is not analogous to the esters (b) and (c). Accordingly, Mertoglu fails to disclose the ester (b) and the ester (c). Mertoglu fails to disclose at least these features. Applicant's arguments have been fully considered but they are not persuasive, since Claim 1 recites clearly “one or more solvents selected from the list consisting of:” means prior art only needs to teach a, b or c and does not need to teach all a, b and c. Rejection 2 Applicant argues that Yin appears to be silent with respect to R being a branched C9-C1salkyl and R2 and R3 independently being C1-C4alkyl. Accordingly, Yin fails to disclose "wherein R1 is a branched C9-C1salkyl and R2 and R3 are independently C1-C4alkyl" as recited by independent claim 1. (Emphasis added.) For at least these reasons, Yin fails to disclose the foregoing aspects of independent claim 1, and thus Yin cannot support a prima facie case of anticipation of independent claim I and its dependent claims. Applicant's arguments have been fully considered but they are not persuasive, since similarly to the response above that without specifying branched or not, which means it inherently embraces both straight-chain (unbranched) and branched-chain saturated hydrocarbon radicals. Rejection 3 Applicant argues that Horstmann is silent with respect to an ester analogous to the esters (b) and ( c) set forth in independent claim 1. While Horstmann generally mentions that R may be branched, Horstmann is silent with respect to "wherein R1 is a branched C9-C1salkyl and R2 and R3 are independently C1-C4alkyl." Accordingly, Horstmann fails to disclose "wherein R1 is a branched C9-C1salkyl and R2 and R3 are independently C1-C4alkyl" as recited by independent claim 1. (Emphasis added.) Applicant's arguments have been fully considered but they are not persuasive, since similarly to the response above that without specifying branched or not, which means it inherently embraces both straight-chain (unbranched) and branched-chain saturated hydrocarbon radicals and Claim 1 recites clearly “one or more solvents selected from the list consisting of:” means prior art only needs to teach a, b or c and does not need to teach all a, b and c. Rejection 4 Applicant argues that Bennett fails to disclose the esters (b) and (c) set forth in independent claim 1. In contrast, Bennett appears to disclose a general alkyl benzoate where the carbonyl group is attached to the benzyl group. See Bennett, col. 5 lines 56-58. Applicant respectfully submits that an alkyl benzoate is not analogous to the esters (b) and (c). Instead, an alkyl benzoate would have the general formula benzyl-C(O)-O-Ra where Ra is an alkyl group. Accordingly, the benzyl group is attached to the carbonyl (C=O), rather than the oxygen (O) of the benzoate. With respect to the ester (b), independent claim I recites "an ester of formula R4-C(0)-0Rs, wherein R4 is a branched C4-Csalkyl or isopropyl, and Rs is a methyl or ethyl group substituted with an aromatic substituent selected from phenyl or naphthalenyl". (Emphasis added). Thus, an aromatic group of independent claim 1 is limited to being attached to the O of the ester, rather than the carbonyl carbon (C=O). Accordingly, Bennett fails to disclose the ester (b). With respect to the ester (c), independent claim 1 recites "an ester of formula R6-C(O)-OXR7, wherein R6 is phenyl, benzyl, or naphthalenyl, optionally substituted with up to two methyl groups, X represents a single bond or a C1-C4alkylene group, and R7 is secondary butyl or cyclohexyl." Thus, the claims recite a secondary butyl or cyclohexyl is attached to the O of the ester via X. Applicant's arguments have been fully considered and they are persuasive that Bennett does not teach option b, but they are not persuasive since Bennett teaches option c. Bennett teaches "alkyl", which includes secondary butyl (sec-butyl), tert-butyl, and isobutyl. The mention of butyl benzoate as an example serves to illustrate the carbon chain size, not to restrict the patent scope exclusively to the linear n-butyl chain. Rejection 5 Applicant argues that the formula Ar-X-COOR (1) of Zen is not analogous to the esters (c). Additionally, the Applicant submits that formula RCOO-X-Ar (2) of Zen is not analogous to the esters (b). Zen appears to disclose formula Ar-X-COOR (1) and formula RCOO-X-Ar (2) where the Ar is preferably a phenyl group which may be substituted with at least a one methyl group; X is preferably a single bond, a methylene group or an ethylene group; and R is preferably an alkyl group having I to 6 carbon atoms. See id. Applicant respectfully submits that formula RCOO-X-Ar (2) is not analogous to the esters (b). With respect to formula Ar-X-COOR (1), the Applicant respectfully submit that formula Ar-X-COOR (1) of Zen is missing "wherein R6 is phenyl, benzyl, or naphthalenyl, optionally substituted with up to two methyl groups, X represents a single bond or a C1-C4alkylene group, and R7 is secondary butyl or cyclohexyl, wherein the cyclohexyl is optionally substituted with up to two methyl groups." Applicant's arguments have been fully considered and they are persuasive that Zen does not teach option b, but they are not persuasive since Zen teaches option c. Zen teaches "alkyl", which includes secondary butyl (sec-butyl), tert-butyl, and isobutyl. The mention of butyl benzoate as an example serves to illustrate the carbon chain size, not to restrict the patent scope exclusively to the linear n-butyl chain. Allowable Subject Matter Claims 3-5 and 18 are objected to as being dependent upon a rejected base claim, but would be allowable if rewritten in independent form including all of the limitations of the base claim and any intervening claims. Conclusion No claim is allowed Applicant's amendment necessitated the new ground(s) of rejection presented in this Office action. Accordingly, THIS ACTION IS MADE FINAL. See MPEP § 706.07(a). Applicant is reminded of the extension of time policy as set forth in 37 CFR 1.136(a). A shortened statutory period for reply to this final action is set to expire THREE MONTHS from the mailing date of this action. In the event a first reply is filed within TWO MONTHS of the mailing date of this final action and the advisory action is not mailed until after the end of the THREE-MONTH shortened statutory period, then the shortened statutory period will expire on the date the advisory action is mailed, and any nonprovisional extension fee (37 CFR 1.17(a)) pursuant to 37 CFR 1.136(a) will be calculated from the mailing date of the advisory action. In no event, however, will the statutory period for reply expire later than SIX MONTHS from the mailing date of this final action. Correspondence Any inquiry concerning this communication or earlier communications from the examiner should be directed to NGOC-ANH THI NGUYEN whose telephone number is (571)270-0867. The examiner can normally be reached Monday - Friday 8:00 am. Examiner interviews are available via telephone, in-person, and video conferencing using a USPTO supplied web-based collaboration tool. To schedule an interview, applicant is encouraged to use the USPTO Automated Interview Request (AIR) at http://www.uspto.gov/interviewpractice. If attempts to reach the examiner by telephone are unsuccessful, the examiner’s supervisor, Robert A Wax can be reached on 571-272-0623. The fax phone number for the organization where this application or proceeding is assigned is 571-273-8300. Information regarding the status of published or unpublished applications may be obtained from Patent Center. Unpublished application information in Patent Center is available to registered users. To file and manage patent submissions in Patent Center, visit: https://patentcenter.uspto.gov. Visit https://www.uspto.gov/patents/apply/patent-center for more information about Patent Center and https://www.uspto.gov/patents/docx for information about filing in DOCX format. For additional questions, contact the Electronic Business Center (EBC) at 866-217-9197 (toll-free). If you would like assistance from a USPTO Customer Service Representative, call 800-786-9199 (IN USA OR CANADA) or 571-272-1000. /NGOC-ANH THI NGUYEN/Examiner, Art Unit 1615 /Robert A Wax/Supervisory Patent Examiner, Art Unit 1615
Read full office action

Prosecution Timeline

Nov 16, 2023
Application Filed
Apr 01, 2026
Non-Final Rejection mailed — §102, §112
May 12, 2026
Response Filed
Sep 30, 2026
Final Rejection mailed — §102, §112 (current)

Precedent Cases

Applications granted by this same examiner with similar technology

Patent 12746210
NANOSUSPENSION FORMULATION FOR TREATMENT OF PULMONARY FIBROSIS
2y 8m to grant Granted Sep 29, 2026
Patent 12746211
NOVEL PARTICLE COMPOSITION COMPRISING SIALIC ACID BINDING LIGAND
2y 9m to grant Granted Sep 29, 2026
Patent 12740941
OPHTHALMIC PHARMACEUTICAL COMPOSITIONS OF ROFLUMILAST
4y 0m to grant Granted Sep 22, 2026
Patent 12740937
Ointment or Balm and Method for Producing Same
2y 9m to grant Granted Sep 22, 2026
Patent 12702719
HAIRPIN-LIKE OLIGONUCLEOTIDE-CONJUGATED SPHERICAL NUCLEIC ACID
4y 11m to grant Granted Aug 11, 2026
Study what changed to get past this examiner. Based on 5 most recent grants.

Strategy Recommendation AI-generated — please review before filing

Get a prosecution strategy drawn from examiner precedents, rejection analysis, and claim mapping.
Typically takes 5-10 seconds — AI-generated, attorney review required before filing

Prosecution Projections

3-4
Expected OA Rounds
30%
Grant Probability
76%
With Interview (+46.5%)
3y 5m (~6m remaining)
Median Time to Grant
Moderate
PTA Risk
Based on 67 resolved cases by this examiner. Grant probability derived from career allowance rate.

Sign in with your work email

Enter your email to receive a magic link. No password needed.

Personal email addresses (Gmail, Yahoo, etc.) are not accepted.

Free tier: 3 strategy analyses per month